Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

NCT07005947 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-02-19

No results posted yet for this study

Summary

This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.

Conditions

  • Long COVID-19
  • Acute COVID-19
  • Postural Orthostatic Tachycardia Syndrome (POTS)
  • Diabetic Neuropathy

Sponsors & Collaborators

  • CND Life Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2026-02-28
Completion
2026-04-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07005947 on ClinicalTrials.gov